Skip to main content

Osteomalacia News

Opportunistic CT Bone Density Screening Improves Osteoporosis Screening Rate

MONDAY, March 10, 2025 – Implementing opportunistic computed tomography (CT) bone density screening could increase the osteoporosis screening rate, yielding a reduction in medical costs, according...

Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO)

NOVATO, Calif. and TOKYO, June 18, 2020 (GLOBE NEWSWIRE) – Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Osteoporosis

Related drug support groups

Vitamin D